Calyxt Posts 86% Decline In Q4 Revenue

by Shivani Kumaresan, Benzinga Staff Writer

March 4, 2022 5:19 AM | 1 min read | Make a Comment

Calyxt Inc CLXT reported a fourth-quarter FY21 sales decline of 86% year-on-year, to $1.94 million, missing the consensus of $2.64 million.
The revenue decrease was driven by lower volumes of products sold in 2021 as the company had completed the wind-down of its soybean product line prior to the fourth quarter of 2021.
The operating expenses fell 18.5% YY to $6.6 million. The operating loss for the quarter narrowed to $(6.7) million versus $(13.1) million last year.
The company held $14.4 million in cash and equivalents as of December 31, 2021.
Adjusted EPS of $(0.19) beat the analyst consensus of $(0.41).
Price Action: CLXT shares closed at $1.06 on Thursday.

Posted In: Earnings News Penny Stocks General Briefs

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.